George Clinical, a leading clinical research organization (CRO) operating worldwide, is pleased to announce it has rebranded to become Emerald Clinical Trials.

Novartis today announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia® (atrasentan), a potent and selective endothelin

ERBC, a leading preclinical contract research organization (CRO), and Menarini Biotech, a Menarini Group company, offering services as a custom development

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform

Fluor Corporation announced today that it has received a letter of intent from one of the world’s leading pharmaceutical makers to provide engineering

SHL Medical, a world-leading solutions provider of advanced drug delivery systems, and Kindeva Drug Delivery, a global CDMO and drug delivery expert

Hanmi Pharmaceutical's combination therapy for Obstructive Prostatic Growth (OPG) caused by Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)

Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, today announces a positive opinion from the European Medicines

SHL Medical, a world-leading provider of advanced drug delivery systems supporting a broad spectrum of formulations for subcutaneous administration

DDL, a leading provider of package, product, and material testing services, is pleased to announce the opening of a new Good Manufacturing Practice